December 23, 2022
Melanoma Immunotherapy with GPR182 blockade
Description: Immune checkpoint inhibitor therapy has greatly improved survival of patients with late-stage melanoma. However, about 2/3 of patients do not benefit from this...
March 31, 2026
Description: Immune checkpoint inhibitor therapy has greatly improved survival of patients with late-stage melanoma. However, about 2/3 of patients do not benefit from this...
Apr 06, 2026 ET
Apr 17, 2026 ET - Apr 19, 2026
Apr 19, 2026 PT
May 02, 2026 PT
May 09, 2026 ET